- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02664766
Effects of Long-term Exercise on Various Parameters in Heavy Drinkers
Effects of Long-term Exercise on Psychological, Physiological, Biochemical and Alcohol-related Parameters in Heavy Drinkers
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The mechanism of incentives that lead people to unhealthy habits such as excessive alcohol consumption is not only social, personal, and psychological, but also associated with neurochemical and neurobiological mechanisms.
Several programs have been developed to stop excessive drinking, but the success rates are small, while the relapse rates are very high, reaching up to 90%. Although there is some evidence for the beneficial effects of exercise on alcohol use disorders, research is limited. The present study investigates whether exercise can act as adjunct therapy for alcohol abuse cessation.
One of the basic assumptions is that the appropriate form of exercise in alcoholics will contribute to the secretion of beta-endorphin, which in combination with psychological pleasure, vitality, change of mood, reduced stress, increased confidence, and the shift of attention will help people to follow healthy lifestyles and abhor alcohol.
The research project is divided in three phases. In the first phase, the effect of acute exercise in critical psychological, physiological, biochemical and alcohol-related parameters associated with excessive alcohol consumption will be examined. In the second phase (current study), a long-term exercise program in conjunction with psychological support strategies aimed at alcohol abuse cessation will be developed, implemented and evaluated. Finally, in the third phase, based on the results of the previous phases, awareness programs in adolescent and adult populations will be designed and implemented as well as the dissemination of results and evaluation of the project will take place.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men drinking >14 drinks/week or >4 drinks/occasion; Women drinking >7 drinks/week or >4 drinks/occasion (1 drink = 14 grams of pure alcohol; definition of the NIAAA for drinking at low risk for developing an AUD; NIAAA, 2014)
- Individuals drinking 5 or more drinks on the same occasion on each of 5 or more days in the past 30 days (1 drink = 14 grams of pure alcohol; definition of the Substance Abuse and Mental Health Services Administration for heavy drinking; NIAAA, 2014) Alcohol Use Disorders Identification Test (AUDIT) score>8
Exclusion Criteria:
- Medical conditions or medication use that would preclude participation in aerobic exercise
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control condition
Control condition with no intervention.
Participants will be recording their daily alcohol consumption.
No lifestyle modification during this period.
|
|
Experimental: Exercise training program
Supervised 8-week exercise training program.
Aerobic exercise (walking, jogging) of increasing duration at 50-60% HRR, at least two sessions per week.
|
Supervised 8-week exercise training program.
Aerobic exercise (walking, jogging) of increasing duration at 50-60% HRR, at least two sessions per week.
Participants will be recording their daily alcohol consumption.
Participants will also undergo three trials of acute exercise (before, at the 4th week and at the 8th week of exercise training) in order to investigate whether exercise training can lead to changes in acute responses to exercise.
Each trial involves 30 min of exercise on a cycle ergometer at 50-60% HRR.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in alcohol consumption (grams of alcohol consumed weekly)
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Self-recorded
|
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Changes in Beta-endorphin levels
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Measured by radioimmunoassay (RIA)
|
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Urge to drink
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
According to questionnaire
|
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Cortisol
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Measured by radioimmunoassay (RIA)
|
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Adrenocorticotrophic hormone (ACTH)
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Measured by radioimmunoassay (RIA)
|
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Catecholamines (epinephrine, norepinephrine, dopamine)
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Measured by radioimmunoassay (RIA)
|
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
C-reactive protein (CRP)
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Semi-quantitative estimation with CRP Latex test kit
|
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Complete blood count
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Autoanalyzer Autoanalyzer Autoanalyzer
|
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Lactic acid
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Measured using photometry
|
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Erythrocyte sedimentation rate (ESR)
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Wintrobe Method
|
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
γ-Glutamyltransferase (GGT)
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Measured with commercial kit
|
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Aspartate Aminotransferase (AST)
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Measured with commercial kit
|
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Alanine Aminotransferase (ALT)
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Measured with commercial kit
|
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Sit and reach flexibility test for the hamstrings muscles and lower back
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Each participant sits on the floor with legs stretched out straight ahead, reaches out and holds that position for at 1-2 seconds while the distance is recorded.
|
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Grip strength
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Handgrip strength test
|
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Number of push-ups performed in one minute
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
|
Number of sit-ups performed until exhaustion
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Yannis Theodorakis, PhD, University of Thessaly
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UThessaly 2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Use Disorder
-
Washington State UniversityRecruitingNicotine Use Disorder | Alcohol Use Disorder (AUD)United States
-
University of North Carolina, Chapel HillCompletedAlcohol Use Disorder, Mild | Alcohol Use Disorder, ModerateUnited States
-
Université du Québec à Trois-RivièresCompletedAlcohol Use, Unspecified | Alcohol Use Disorder, MildCanada
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Medical University of South CarolinaNational Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...RecruitingAlcohol Drinking | Substance Use | Alcohol Use Disorder | Drinking, Alcohol | Alcohol Use Disorder (AUD)United States
-
Kaiser PermanenteNORC at the University of Chicago; Agency for Healthcare Research and Quality... and other collaboratorsCompleted
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Central Institute of Mental Health, MannheimNot yet recruitingAlcohol Use Disorder (AUD)Germany
-
Massachusetts General HospitalMbarara University of Science and TechnologyCompletedAlcohol Use Disorder (AUD)Uganda
-
ITAB - Institute for Advanced Biomedical TechnologiesNot yet recruitingNeurobiological Effects of Transcranial Direct Current Stimulation Treatment in Alcohol Use DisorderAlcohol Dependence | Alcohol-Related Disorders | Substance Use Disorders | Drug Abuse | Mental Disorder | Alcohol Abuse | Alcohol Use Disorder (AUD)
Clinical Trials on Exercise training program
-
Philip Morris Products S.A.CompletedSmoking | Exercise CapacityGermany
-
Riphah International UniversityCompleted
-
Universidad Pablo de OlavideUniversity of SevilleCompletedObesity | Overweight and Obesity | Overweight or ObesitySpain
-
University of FloridaRecruitingStrokeUnited States
-
Chang Gung Memorial HospitalCompletedModerate to Severe COPD Receiving Home Exercise TrainingTaiwan
-
University of Illinois at ChicagoRecruitingMultiple SclerosisUnited States
-
Universidade Federal de Sao CarlosCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil
-
Dana-Farber Cancer InstituteBreast Cancer Research FoundationNot yet recruitingBreast Cancer | Breast Cancer FemaleUnited States
-
Imam Abdulrahman Bin Faisal UniversityCompletedSickle Cell DiseaseSaudi Arabia
-
Centro Hospitalar do PortoUniversidade do Porto; Aveiro UniversityCompleted